STRATEGIC TECHNOLOGY BIOCONSULTING LIMITEDActive
Key figures
Like most small UK companies, STRATEGIC TECHNOLOGY BIOCONSULTING LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2019/20 | 2020/21 | 2021/22 | 2022/23 | 2024/25 | |
|---|---|---|---|---|---|
| Turnover | 8,900 | — | — | — | — |
| Profit for the year | 2,117 | — | — | — | — |
| Total assets | 12,673 | 65 | 11,691 | 5,909 | 2,193 |
| Total liabilities | 21,874 | 275 | — | — | 0 |
| Net assets / total equity | -9,201 | -210 | 11,691 | 5,909 | 2,193 |
| Average number of employees | 1 | 1 | 1 | 1 | 1 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: STRATEGIC TECHNOLOGY BIOCONSULTING LIMITED
Company
STRATEGIC TECHNOLOGY BIOCONSULTING LIMITED is a private limited company registered with Companies House under company number 11630718. It was incorporated on 18 Oct 2018. Its status is active. The registered office is in Cambridge (CB22). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were £2,193, down 62.9% on the previous year. Total assets were £2,193 and total liabilities £0. The company had an average of 1 employee. Figures are available for 5 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 31 Oct 2026.